Avidity Biosciences Statistics
Total Valuation
RNA has a market cap or net worth of $4.32 billion. The enterprise value is $3.41 billion.
Market Cap | 4.32B |
Enterprise Value | 3.41B |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
Earnings Date | Aug 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
RNA has 95.64 million shares outstanding. The number of shares has increased by 23.82% in one year.
Shares Outstanding | 95.64M |
Shares Change (YoY) | +23.82% |
Shares Change (QoQ) | +14.62% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 396.98 |
Forward PS | 257.70 |
PB Ratio | 5.19 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 313.53 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.47, with a Debt / Equity ratio of 0.01.
Current Ratio | 12.47 |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -38.00% and return on invested capital (ROIC) is -30.38%.
Return on Equity (ROE) | -38.00% |
Return on Assets (ROA) | -33.10% |
Return on Capital (ROIC) | -30.38% |
Revenue Per Employee | $42,964 |
Profits Per Employee | -$903,877 |
Employee Count | 253 |
Asset Turnover | 0.02 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +339.77% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +339.77% |
50-Day Moving Average | 34.60 |
200-Day Moving Average | 18.87 |
Relative Strength Index (RSI) | 67.81 |
Average Volume (20 Days) | 1,751,269 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, RNA had revenue of $10.87 million and -$228.68 million in losses. Loss per share was -$2.96.
Revenue | 10.87M |
Gross Profit | 10.87M |
Operating Income | -255.19M |
Pretax Income | -228.68M |
Net Income | -228.68M |
EBITDA | -223.21M |
EBIT | -228.68M |
Loss Per Share | -$2.96 |
Balance Sheet
The company has $916.17 million in cash and $9.15 million in debt, giving a net cash position of $907.02 million or $9.48 per share.
Cash & Cash Equivalents | 916.17M |
Total Debt | 9.15M |
Net Cash | 907.02M |
Net Cash Per Share | $9.48 |
Equity (Book Value) | 830.90M |
Book Value Per Share | 8.69 |
Working Capital | 859.52M |
Cash Flow
In the last 12 months, operating cash flow was -$140.48 million and capital expenditures -$3.32 million, giving a free cash flow of -$143.80 million.
Operating Cash Flow | -140.48M |
Capital Expenditures | -3.32M |
Free Cash Flow | -143.80M |
FCF Per Share | -$1.65 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,347.64% and -2,103.78%.
Gross Margin | 100.00% |
Operating Margin | -2,347.64% |
Pretax Margin | -2,103.78% |
Profit Margin | -2,103.78% |
EBITDA Margin | -2,053.47% |
EBIT Margin | -2,103.78% |
FCF Margin | -1,322.91% |
Dividends & Yields
RNA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -23.82% |
Shareholder Yield | -23.82% |
Earnings Yield | -5.30% |
FCF Yield | -3.33% |
Analyst Forecast
The average price target for RNA is $45.86, which is 1.64% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $45.86 |
Price Target Difference | 1.64% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 146.17% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
RNA has an Altman Z-Score of 20.83 and a Piotroski F-Score of 3.
Altman Z-Score | 20.83 |
Piotroski F-Score | 3 |